|
[1]
|
Garcia, D. and Erkan, D. (2018) Diagnosis and Management of the Antiphospholipid Syndrome. The New England Journal of Medicine, 378, 2010-2021. [Google Scholar] [CrossRef]
|
|
[2]
|
Melayah, S., Changuel, M., Mankaï, A. and Ghedira, I. (2020) IgA Is the Predominant Isotype of Anti-β2 Glycoprotein I Antibodies in Rheumatoid Arthritis. Journal of Clinical Laboratory Analysis, 34, e23217. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Pontara, E., Bison, E., Cattini, M.G., Tonello, M., Denas, G. and Pengo, V. (2023) Close Link between Antiphosphatidylserine/Prothrombin Antibodies, Lupus Anticoagulant, and Activated Protein C Resistance in Tetra Antiphospholipid Antibody-Positive Subjects. Journal of Thrombosis and Haemostasis, 21, 3138-3144. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Hisada, R. and Atsumi, T. (2023) An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus. Biomolecules, 13, Article No. 617. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
宋佳敏, 达展云. 抗心磷脂抗体与系统性红斑狼疮患者凝血指标相关性研究[J]. 南通大学学报: 医学版, 2018, 175(3): 25-28.
|
|
[6]
|
Li, J., Xu, D., Li, H.L., et al. (2017) Evaluation of Failed Immunotherapy among Patients with Negative APLA Recurrent Spontaneous Abortion by Serum Anticardiolipin Antibodies and Mononuclear Cell of Tim-1. European Review for Medical and Pharmacological Sciences, 21, 908-912.
|
|
[7]
|
Abdullahi, Z.G., Abdul, M.A., Aminu, S.M., et al. (2016) Antiphospholipid Antibodies among Pregnant Women with Recurrent Fetal Wastage in a Tertiary Hospital in Northern Nigeria. Annals of African Medicine, 15, 133-137. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
李成霞, 刘淑芳, 包金鸽, 等. 抗β2糖蛋白1抗体与系统性红斑狼疮临床表现的相关性[J]. 世界最新医学信息文摘, 2021, 21(29): 88-89, 109.
|
|
[9]
|
吕晓兰, 戴钰, 吴洪业, 等. aβ2-GP I抗体、ACA及免疫水平与URSA的相关性研究[J]. 检验医学与临床, 2020, 17(23): 3401-3403.
|
|
[10]
|
杜巍, 于玲, 葛文玉, 等. aCL及aβ2GP I联合检测在aPL相关性习惯性流产诊断中的价值[J]. 中国卫生标准管理, 2023, 14(1): 58-61.
|
|
[11]
|
于秀丽, 王晓玲, 李忠信, 等. 抗磷脂综合征的检测与诊断现状[J]. 医学检验与临床2020, 31(11): 39-42.
|
|
[12]
|
Doley, D., Kakati, S., Saikia, L., et al. (2017) A Comparative Study of Anticardiolipin Anti-bodies among Systemic Lupus Erythematosus Patients from Western and Eastern India. Journal of the Association of Physicians of India, 65, 14-19.
|
|
[13]
|
Fabrizio, C., Roberta, P., Cristiano, S., et al. (2017) Diagnosis of Catastrophic An-ti-Phospholipid Syndrome in a Patient Tested Negative for Conventional Tests. Clinical and Experimental Rheumatology, 35, 678-679.
|
|
[14]
|
张蜀澜, 吴子燕, 陈思, 等. 不同亚型抗磷脂抗体在系统性红斑狼疮诊断中的价值[J]. 中华检验医学杂志, 2014, 37(8): 597-602.
|
|
[15]
|
张文兰, 白力, 胡同平. 抗IgG、IgM、IgA型心磷脂抗体和抗β2糖蛋白1抗体在系统性红斑狼疮患者中的意义[J]. 免疫学杂志, 2017, 33(1): 59-62.
|
|
[16]
|
姚文瑛, 须静. 不同亚型ACL和aβ2GP I在SLE患者发病及病情发展中的临床意义[J]. 国际检验医学杂志, 2021, 42(2): 202-205.
|
|
[17]
|
Mehrani, T. and Petri, M. (2011) IgM Anti-β2 Glycoprotein I Is Protective against Lupus Nephritis and Renal Damage in Systemic Lupus Erythematosus. The Journal of Rheumatology, 38, 450-453. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Mehrani, T. and Petri, M. (2011) Association of IgA Anti-beta2 Gly-coprotein 1 with Clinical and Labomtory Manifestations of Systemic Lupus Erythematosus. The Journal of Rheumatolo-gy, 38, 64-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
周红, 王美美, 陈巧林. 系统性红斑狼疮患者抗β2糖蛋白I抗体检测的意义[J]. 检验医学, 2007, 22(2): 105-107.
|
|
[20]
|
于淼琛, 姜艳, 梅, 潘立阳, 等. 抗磷脂抗体与狼疮性肾炎的相关性研究[J]. 中国免疫学杂志2022, 38(24): 3037-3040, 3045.
|
|
[21]
|
曾晓虹, 薛原. 抗β2糖蛋白I抗体在系统性红斑狼疮合并自身免疫性溶血性贫血中的意义[J]. 中华临床免疫和变态反应杂志, 2014, 8(1): 28-33.
|
|
[22]
|
Shen, Y., Chen, X.W., Sun, C.Y., et al. (2010) Association between Anti-Beta2 Glycoprotein Antibodies and Renal Glomerular C4d Deposition in Lupus Nephritis Patients with Glomerular Microthmmbosis: A Prospective Study of 155 Cases. Lupus, 19, 1195-1203. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
陈华良, 廖永强, 任妹, 等. 血清IFN-α、aCL和抗β2-GP I抗体与系统性红斑狼疮患者血小板减少的相关性[J]. 西部医学, 2021, 33(10): 1549-1552, 1556.
|
|
[24]
|
Ktona, E., et al. (2014) Evaluation of Thrombocytopenia in Systemic Lupus Erythema-tosus and Correlation with Different Organs Damages. Materia Socio-Medica, 26, 122-124.
|
|
[25]
|
郭文玲, 薛原, 曾晓虹. 抗β2糖蛋白I抗体在系统性红斑狼疮患者血栓形成中的作用[J]. 中华临床免疫和变态反应杂志, 2014, 8(3): 211-215.
|
|
[26]
|
廖书生, 叶腾, 倪显达, 等. 系统性红斑狼疮患者心脏瓣膜病变的超声心动图特征及危险因素分析[J]. 中国循环杂志, 2022, 37(7): 695-700.
|
|
[27]
|
Smolen, J.S., Aletaha, D., Barton, A., et al. (2018) Rheumatoid Ar-thritis. Nature Reviews Disease Primers, 4, 18001. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Pahor, A., Hojs, R., Holc, I., et al. (2006) Antiphospholipid Antibodies as a Possible Risk Factor for Atherosclerosis in Patients with Rheumatoid Arthritis. Immunobiology, 211, 689-694. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Merashli, M., Alves, J.D., Gentile, F. and Ames, P.R.J. (2017) Relevance of Antiphospholipid Antibodies in Multiple Sclerosis: A Systematic Review and Meta-Analysis. Seminars in Arthritis and Rheumatism, 46, 810-818. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Greco, A., Minghetti, L., Sette, G., Fieschi, C. and Levi, G. (1999) Cerebrospinal Fluid Isoprostane Shows Oxidative Stress in Patients with Multiple Sclerosis. Neurology, 53, 1876-1879. [Google Scholar] [CrossRef]
|
|
[31]
|
Smith, K.J. and Lassmann, H. (2002) The Role of Nitric Oxide in Multiple Sclerosis. The Lancet Neurology, 1, 232-241. [Google Scholar] [CrossRef]
|
|
[32]
|
Hemmer, B., Kerschensteiner, M. and Korn, T. (2015) Role of the Innate and Adaptive Immune Responses in the Course of Multiple Sclerosis. The Lancet Neurology, 14, 406-419. [Google Scholar] [CrossRef]
|
|
[33]
|
Matsuura, E., Lopez, L.R., Shoenfeld, Y. and Ames, P.R. (2012) β2-Glycoprotein I and Oxidative Inflammation in Early Atherogenesis: A Progression from Innate to Adaptive Immunity? Autoimmunity Reviews, 12, 241-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Karussis, D., Leker, R.R., Ashkenazi, A. and Abramsky, O. (1998) A Subgroup of Multiple Sclerosis Patients with Anticardiolipin Antibodies and Unusual Clinical Manifestations: Do They Represent a New Nosological Entity? Annals of Neurology, 44, 629-634. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
彭文华, 范书英, 王勇, 等. 抗β2糖蛋白I型抗体与急性冠脉综合征相关性研究[J]. 内科急危重症杂志, 2011, 17(3): 142-144.
|
|
[36]
|
Bily, A., Moss, A.J., Francis, C.W., et al. (2000) Anticardiolipin Antibodies and Recurrent Coronary Events. Circulation, 102, 1258-1263. [Google Scholar] [CrossRef]
|
|
[37]
|
Meroni, P.L., Peyvandi, F., Foco, L., Bernardinelli, L., Fetiveau, R., Mannucci, P.M. and Tincani, A. (2007) Anti-Beta2 Glycoprotein I Antibodies and the Risk of Myocardial Infarction in Young Premenopausal Women. Journal of Thrombosis and Haemostasis, 5, 2421-2428. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
吴雁, 胡进访. 缺血性脑卒中与同型半胱氨酸、血尿酸、hs-CRP水平的相关性分析[J]. 山东医药, 2013, 53(29): 80-81.
|
|
[39]
|
翟莉红. 缺血性脑卒中患者血清同型半胱氨酸水平与颈动脉粥样硬化的相关性[J]. 山东医药, 2015, 55(42): 94-95.
|
|
[40]
|
刘坦, 孟晓峰. β2糖蛋白I抗体在缺血性脑卒中的作用研究[J]. 中国卫生检验杂志, 2020, 30(4): 448-450.
|
|
[41]
|
陶洪群, 李小龙, 王慧燕, 等. 不同亚型抗磷脂抗体、同型半胱氨酸与缺血性脑卒中的相关性研究[J]. 中国卫生检验杂志, 2020, 30(3): 297-299, 303.
|
|
[42]
|
Horstman, L.L., Jy, W., Bidot, C.J., et al. (2009) Antiphospholipid Antibodies: Paradigm Transition. Journal of Neuroinflammation, 6, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
El-Assaad, F., Krilis, S.A. and Giannakopoulos, B. (2016) Posttranslational Forms of Beta2-Glycoprotein I in the Pathogenesis of the Antiphospholipid Syndrome. Thrombosis Journal, 14, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Rikarni, D.R., Tambunan, K.L., Isbagyo, H., Dewi, B.E., Acang, N., Setiabudy, R. and Aman, A.K. (2015) Prothrombotic Effect of Anti-Beta-2 Glycoprotein-1 Antibodies on the Ex-pression of Tissue Factor, Thrombomodulin, and Plasminogen Activator Inhibitor-1 in Endothelial Cells. Acta Medica Indonesiana, 47, 31-37.
|
|
[45]
|
Ho, Y.C., Ahuja, K.D.K. and Adams, M.J. (2018) Further Investigations of the Effects of Anti-β2GP1 Antibodies on Collagen-Induced Platelet Aggregation. Clinical and Applied Thrombosis/Hemostasis, 24, 1128-1133. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Pérez, D. and Serrano, A. (2017) New Biomarker to Predict Thrombosis Inpatients with Antiphospholipid Antibodies: Immune Complexes of Beta2 Glycoprotein 1. The Israel Med-ical Association Journal, 19, 646-647.
|
|
[47]
|
张晓姗. 静脉用免疫球蛋白联合补肾化瘀汤治疗原因不明复发性自然流产的疗效及对血栓前状态和外周血Th17/Treg免疫失衡的影响[J]. 现代中西医结合杂志, 2017, 26(35): 3903-3905, 3919.
|
|
[48]
|
贾丽媛, 奚永志, 孙玉英. 免疫学因素在原因不明复发性自然流产发病机制中的研究进展[J]. 解放军医学院学报, 2020, 41(4): 404-408, 412.
|
|
[49]
|
曾国富, 章芸, 李梅桂, 等. 低分子肝素联合主动免疫治疗不明原因复发性自然流产的临床研究[J]. 北方药学, 2019, 16(11): 119-120.
|
|
[50]
|
李丽, 王彬. 复发性自然流产患者血清抗心磷脂抗体、抗β2糖蛋白1抗体的表达及临床意义[J]. 当代医药论丛, 2021, 19(21): 148-149.
|
|
[51]
|
程建华. 复发性自然流产与免疫因素的关系及其不同方法治疗的效果研究[J]. 临床合理用药杂志, 2019, 6(9): 17-18.
|
|
[52]
|
尹红, 魏然, 张振, 等. 原因不明复发性自然流产患者血清IL-10水平变化及其与miR-513c-5p的调控关系[J]. 山东医药, 2021, 61(2): 30-34.
|
|
[53]
|
谷兆琪, 尹训强, 王东梅, 等. 原因不明复发性自然流产患者外周血IL-6、let-7d-5p水平变化及其关系[J]. 山东医药, 2019, 59(2): 23-27.
|
|
[54]
|
李杰兰, 马卫军. 主动免疫治疗不明原因复发性自然流产的临床分析[J]. 齐齐哈尔医学院报, 2019, 33(14): 1865-1866.
|
|
[55]
|
赵曼林, 林小民, 湛冰, 等. 联合免疫治疗对复发性自然流产患者外周血 Th1/Th2的影响[J]. 广东医学院学报, 2012, 30(5): 496-497, 500.
|
|
[56]
|
Xu, J., Chen, D., Duan, X., Li, L., Tang, Y. and Peng, B. (2019) The Association between Antiphospholipid Antibodies and Late Fetal Loss: A Systematic Review and Meta-Analysis. Acta Obstetricia et Gynecologica Scandinavi-ca, 98, 1523-1533. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Shoenfeld, Y., Carp, H.J., Molina, V., Blank, M., Cervera, R., Balasch, J., Tincani, A., Faden, D., Lojacono, A., Doria, A., Konova, E. and Meroni, P.L. (2006) Autoanti-bodies and Prediction of Reproductive Failure. American Journal of Reproductive Immunology, 56, 337-344. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
李娜, 荣扬, 王珍光. 抗-β2糖蛋白1抗体在女性不孕症及先兆性流产中的检测及意义[J]. 现代检验医学杂志, 2015(2): 42-45.
|
|
[59]
|
Hornstein, M.D., Davis, O.K., Massey, J.B., Paulson, R.J. and Collins, J.A. (2000) Antiphospholipid Antibodies and in Vitro Fertilization Success: A Me-ta-Analysis. Fertility and Sterility, 73, 330-333. [Google Scholar] [CrossRef]
|
|
[60]
|
Paulmyer-Lacroix, O., Despierres, L., Courbiere, B. and Bardin, N. (2014) Antiphospholipid Antibodies in Women Undergoing in Vitro Fertilization Treatment: Clinical Value of IgA Anti-β2 Glycoprotein I Antibodies Determination. BioMed Research International, 2014, Article ID: 314704. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Chighizola, C.B., Pregnolato, F., Raschi, E., Grossi, C., Gentilini, D., Borghi, M.O., Chen, P. and Meroni, P.L. (2016) Antiphospholipid Antibodies and Infertility: A Gene Expression Study in Decidual Stromal Cells. IMAJ, 18, 146-149.
|
|
[62]
|
Prieto-Garcia, A., Sloane, D.E., Gargiulo, A.R., Feldweg, A.M. and Castells, M. (2011) Autoimmune Progesterone Dermatitis: Clinical Presentation and Management with Progesterone Desensitization for Successful in Vitro Fertilization. Fertility and Sterility, 95, 1121. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Van Pampu, M.G., Dekker, G.A., Wolf, H., et al. (1999) High Prevalence of Hemostatic Abnormalities in Woman with a Histoh of Severe Preeclampsia. American Journal of Obstet-rics & Gynecology, 180, 1146-1150. [Google Scholar] [CrossRef]
|
|
[64]
|
Branch, D.W., Sliver, R.M. and Blackwell, J.L. (1992) Out-come of Treated Pregnancies in Woman with a Antiphospholipid Syndrome: An Update of the Utah Experience. Obstet-rics & Gynecology, 80, 614-620.
|
|
[65]
|
Faden, D., Tincani, A., Tanzi, P., et al. (1997) Anti-Beta2 Glycoprotein I Anti-bodies Are Associated with Some Obstetrical Complications, Mainly Preeclampsia-Eclampsia. The European Journal of Obstetrics & Gynecology and Reproductive Biology, 73, 37-42. [Google Scholar] [CrossRef]
|
|
[66]
|
张红萍, 何海珍, 郑加勇, 等. 妊娠期高血压疾病孕妇检测抗心磷脂抗体与β2糖蛋白1型抗体的临床价值[J]. 温州医学院学报, 2010, 40(3): 286-288.
|